Craniofacial resection for sinunasal tumors |
| |
Authors: | M. Granados-García M. A. Celis-López J. L. Aguilar-Ponce V. Villavicencio-Valencia K. Luna-Ortíz A. Poitevin-Chacón F. Carrillo-Hernández A. Herrera-Gómez |
| |
Affiliation: | (1) Department of Medical Oncology at the Instituto Nacional de Cancerología, México, Tlalpan, México;(2) Department of Radiotherapy at the Instituto Nacional de Cancerología, México, Tlalpan, México;(3) Head and Neck Department, Instituto Nacional de Cancerología, Av. San Fernando, 22, Tlalpan, 14080 México D.F. |
| |
Abstract: | Introduction Malignant sinunasal tumors are very rare in Mexico. They ussually present as advanced disease because it is extremely difficult to make an early diagnosis; in addition, its treatment is complicated by a variety of lesions. Surgical resection remains the mainstay of treatment, but its relative therapeutic value compared with alternative treatments is controversial. Objective We undertook a retrospective analysis in order to evaluate results of craniofacial resections for sinunasal tumors. Materials and methods A total of 20 patients, 11 men and 9 women were considered, median age was 49 years (18–74). Eleven had received previous treatment elsewhere. In 13 patients tumor was limited to maxilo-etmoidal complex, but in 6 cases tumor involved anteroinferior aspect of esfenoidal sinus, in 7 extended to the orbit, in 3 to dura and two to the brain. One had cervical metastases. Median tumoral size was 5.8 cm (1–10). Results Overall complication rate was 50%. Major surgical complications occurred in 4 patients (20%): one patient developed isolated cerebrobrpinal fluid leakage (CEFL), 1 developed deterioration of mental status, and two developed meningitis associated with CEFL. Late complications occurred in 30% of the patients. There was not any operative death. Eleven patients received postoperative radiotherapy. Fifteen patients recurred. There were 11 local relapses, although one associated with a regional relapse, and another with regional and distant relapse. There were four isolated regional fails and six isolated distant failures. Three year overall survival was 65%, and 3-year disease free survival was 50%. Patients without previous treatment median survival was 28.3 months, meanwhile with previous treatment was 18.2 months. Conclusions Craniofacial resection is a safe and valuable tool in the treatment of advanced sinunasal tumors involving cranial base. |
| |
Keywords: | head and neck cancer cranial base tumors craniofacial resections results |
本文献已被 SpringerLink 等数据库收录! |
|